Targeting Angiogenesis and Tumor Microenvironment in Metastatic Colorectal Cancer: Role of Aflibercept

In the last decades, we have progressively observed an improvement in therapeutic options for metastatic colorectal cancer (mCRC) treatment with a progressive prolongation of survival. mCRC prognosis still remains poor with low percentage of 5-year survival. Targeted agents have improved results obt...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Giordano, Guido, Febbraro, Antonio, Venditti, Michele, Campidoglio, Serena, Olivieri, Nunzio, Raieta, Katia, Parcesepe, Pietro, Imbriani, Giusy Carmen, Remo, Andrea, Pancione, Massimo
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Hindawi Publishing Corporation 2014
Gaiak:
Review Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4130202/
https://ncbi.nlm.nih.gov/pubmed/25136356
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/526178
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak